Complement Component C5a Permits the Coexistence of Pathogenic Th17 Cells and Type I IFN in Lupus

Journal of Immunology - United States
doi 10.4049/jimmunol.1401322
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

Complement Component 5a (C5A; C5); Complement 5a Receptor 1 (C5AR1)

Science-Business eXchange
2008English

Cutting Edge: Intracellular IFN-β and Distinct Type I IFN Expression Patterns in Circulating Systemic Lupus Erythematosus B Cells

Journal of Immunology
AllergyImmunology
2018English

Neutralizing Type I IFN Antibodies Trigger an IFN-Like Response in Endothelial Cells

Journal of Immunology
AllergyImmunology
2008English

Interplay Between Pathogenic Th17 and Regulatory T Cells

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2007English

The Complement System in Bullous Pemphigoid. I. COMPLEMENT AND COMPONENT LEVELS IN SERA AND BLISTER FLUIDS

Journal of Clinical Investigation
Medicine
1973English

The Type I IFN of Bos Taurus

English

B Cells Control Lupus Autoimmunity by Inhibiting Th17 and Promoting Th22 Cells

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2020English

Coexistence of Tumid Lupus Erythematosus and Discoid Lupus Erythematosus

Actas Dermo-Sifiliograficas
DermatologyForensic MedicinePathologyHistology
2019English

Complement Factor C5a and C5a Receptor Contribute to Morphine Tolerance and Withdrawal-Induced Hyperalgesia in Rats

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy